Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' DEFICIT (Details Narrative)

STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)					1 Months Ended			6 Months Ended	12 Months Ended
STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)	Feb. 26, 2021	Sep. 22, 2020	Jun. 15, 2020	Dec. 29, 2017	Mar. 31, 2021	Feb. 29, 2020	Oct. 31, 2018	Jul. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2018	Sep. 29, 2021	Feb. 09, 2021	Jun. 29, 2020	Jan. 31, 2020	Jul. 17, 2019	Jul. 16, 2019
Class Of Warrant Or Right [Line Items]
Convertible notes principal amount									$ 18,007,000	$ 13,574,000
Debt instrument exercise price		$ 2.00				$ 3.00									$ 5.87
Percentage of monthly payments interest rate						10.00%
Maturity date						Apr. 21, 2021
Conversion debentures price						$ 3.00									$ 9.52
Stock price														$ 1.67
Common stock purchase period		5 years
Loss on debt extinguishment, net									$ 365,000	$ 1,425,000
Common stock, issued									49,311,864	48,987,189
Share-based compensation									$ 553,000	$ 739,000
Period remaining for recognition of unrecognized compensation cost									1 year 2 months 12 days
Addition to equity for common stock										142,000
Research and development									$ 4,110,000	$ 2,408,000
Common Stock [Member]
Class Of Warrant Or Right [Line Items]
Common stock shares issued for consideration										515,743
Addition to equity for common stock										$ 1,000
2011 Stock Incentive Option Plan [Member]
Class Of Warrant Or Right [Line Items]
Exercise price - options										$ 2.05
Total unrecognized compensation cost									$ 21,000
2011 Stock Incentive Option Plan [Member] \| Adjustment of Merger Exchange Ratio [Member]
Class Of Warrant Or Right [Line Items]
Exercisable term									10 years
2011 Stock Incentive Option Plan [Member] \| Adjustment of Merger Exchange Ratio [Member] \| Common Stock [Member]
Class Of Warrant Or Right [Line Items]
Stock options granted to purchase common stock									0
Exercise price - options									$ 2.05
2011 Stock Incentive Option Plan [Member] \| Adjustment of Merger Exchange Ratio [Member] \| Share Based Compensation Award, Tranche One [Member]
Class Of Warrant Or Right [Line Items]
Vesting period									1 year
Vesting percentage									33.33%
2011 Stock Incentive Option Plan [Member] \| Adjustment of Merger Exchange Ratio [Member] \| Share Based Compensation Award, Tranche Two [Member]
Class Of Warrant Or Right [Line Items]
Vesting period									2 years
Vesting percentage									66.67%
2011 Stock Incentive Option Plan [Member] \| Stock Options [Member]
Class Of Warrant Or Right [Line Items]
Number of shares authorized under the plan											9,000,000
Expiration period									10 years
Vesting period									3 years
Share-based compensation									$ 553,000	$ 739,000
2021 Stock Incentive Option Plan [Member]
Class Of Warrant Or Right [Line Items]
Common stock, issued												4,000,000
Kainos Medicine, Inc [Member]
Class Of Warrant Or Right [Line Items]
Payments to research and development expense	$ 500,000
Common stock shares issued for consideration	324,675
Addition to equity for common stock	$ 500,000
Research and development									$ 1,500,000
Amended and Restated Warrants [Member]
Class Of Warrant Or Right [Line Items]
Debt instrument exercise price					$ 1.54	2.00										$ 5.87
Amended Previous Issued Warrant [Member]
Class Of Warrant Or Right [Line Items]
Debt face amount percentage									1,365,189
Debt instrument exercise price									$ 4.76
Securities Amendment Agreement [Member]
Class Of Warrant Or Right [Line Items]
Maturity date		Aug. 31, 2021						Apr. 21, 2021
Monthly redemption payment on principal amount		$ 500,000,000						$ 1,000,000,000
Monthly redemptions description									Pursuant to the Allonge, the aggregate monthly redemption payments under the Debentures were reduced to $500,000 from $1,000,000 in principal amount and the maturity date of the Debentures was extended from April 21, 2021 to August 31, 2021. The monthly redemption payments resumed in September 2020.
Convertible Bond Purchase Agreement [Member] \| T.R. Winston & Company, LLC [Member]
Class Of Warrant Or Right [Line Items]
Debt instrument exercise price											$ 2.10
Maximum [Member]
Class Of Warrant Or Right [Line Items]
Number of common stock to be purchased		1,840,000
Maximum [Member] \| 2011 Stock Incentive Option Plan [Member] \| Adjustment of Merger Exchange Ratio [Member] \| Common Stock [Member]
Class Of Warrant Or Right [Line Items]
Stock options granted to purchase common stock										90,000
Maximum [Member] \| Convertible Bond Purchase Agreement [Member] \| T.R. Winston & Company, LLC [Member]
Class Of Warrant Or Right [Line Items]
Number of common stock to be purchased											75,000
Amended and Restated Debentures [Member]
Class Of Warrant Or Right [Line Items]
Debt instrument exercise price						2.00
Conversion debentures price						$ 2.00
Initial shares under purchase agreement						100,000
Stock price						$ 2.00
10% Secured Senior Debentures [Member]
Class Of Warrant Or Right [Line Items]
Percentage of monthly payments interest rate					10.00%				10.00%
Loss on debt extinguishment, net					$ 1,200,000
Convertible Promissory Note [Member]
Class Of Warrant Or Right [Line Items]
Stock price									$ 1.67	$ 1.68
Number outstanding									1,250,000	1,250,000
Convertible Promissory Note [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Convertible notes principal amount			$ 3,150,000
Debt instrument exercise price			$ 2.05
Percentage of monthly payments interest rate			12.00%							11.00%			2.00%
Conversion price													$ 1.48
Extended maturity date			Jun. 15, 2023
Number outstanding			1,250,000
Loss on debt extinguishment, net			$ 1,400,000
Expected life (in years)			5 years
Convertible Promissory Note [Member] \| Maximum [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Convertible notes aggregate purchase price													$ 17,000,000
Senior Secured Convertible Debentures [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Percentage of monthly payments interest rate									10.00%
Senior Secured Convertible Debentures [Member] \| Amended and Restated Debentures [Member] \| Securities Amendment Agreement [Member]
Class Of Warrant Or Right [Line Items]
Percentage of monthly payments interest rate		10.00%
GPB Debt Holdings II, LLC [Member]
Class Of Warrant Or Right [Line Items]
Percentage of monthly payments interest rate																	10.00%
GPB Debt Holdings II, LLC [Member] \| Amended and Restated Warrants [Member]
Class Of Warrant Or Right [Line Items]
Debt instrument exercise price																	$ 10.00
GPB Debt Holdings II, LLC [Member] \| Maximum [Member] \| Amended and Restated Warrants [Member]
Class Of Warrant Or Right [Line Items]
Debt face amount percentage																	1,460,000
GPB Debt Holdings II, LLC [Member] \| Senior Secured Convertible Promissory Note [Member]
Class Of Warrant Or Right [Line Items]
Debt face amount percentage				240,764
Debt instrument exercise price				$ 10.80
Initial warrants exercisable period after issuance				5 years
GPB Debt Holdings II, LLC [Member] \| Purchase Agreement With 10% Senior Secured Debentures [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Percentage of monthly payments interest rate							10.00%
Principal amount of debentures and warrants issued							$ 12,200,000
Debenture and warrants issued to original loan							$ 13,200,000
GPB Debt Holdings II, LLC [Member] \| Purchase Agreement With 10% Senior Secured Debentures [Member] \| Maximum [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Number of common stock to be purchased							1,220,000
GPB Debt Holdings II, LLC [Member] \| Amended and Restated Debentures [Member]
Class Of Warrant Or Right [Line Items]
Conversion price																	$ 10.00
GPB Debt Holdings II, LLC [Member] \| Convertible Debt [Member] \| Senior Secured Convertible Promissory Note [Member]
Class Of Warrant Or Right [Line Items]
Convertible notes principal amount				$ 13,000,000
Convertible notes aggregate purchase price				$ 12,500,000
Original issue discount percentage				4.00%